Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions

Glioblastoma (GBM) is among the most fatal and recurring malignant solid tumors. It arises from the GBM stem cell population. Conventional neurosurgical resection, temozolomide (TMZ)-dependent chemotherapy and radiotherapy have rendered the prognosis of patients unsatisfactory. Radiotherapy and chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingming, Wang, Xiaojie, Jin, Xiaoyan, Zhou, Jingjing, Zhang, Yufu, Yang, Yiyuan, Liu, Yusi, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248152/
https://www.ncbi.nlm.nih.gov/pubmed/37304305
http://dx.doi.org/10.3389/fimmu.2023.1175118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248152/
https://www.ncbi.nlm.nih.gov/pubmed/37304305
http://dx.doi.org/10.3389/fimmu.2023.1175118

Ejemplares similares